Roche Holding AG (ROG) agreed to buy Genia Technologies Inc. for as much as $350 million as part of an expansion in the gene-sequencing market.
Roche will pay $125 million in cash and as much as $225 million in further payments based on the achievement of certain goals, the Basel-based company said today in a statement.
“Genia’s proprietary technology is expected to reduce the price of sequencing while increasing speed and sensitivity,” Roche said.
To contact the reporter on this story: Thomas Mulier in Geneva at firstname.lastname@example.org
To contact the editors responsible for this story: David Risser at email@example.com John Bowker, Kim McLaughlin